Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

ACC 2025 Insights: Cardiac Function, Clinical Outcomes and Effect of…

ACC 2025 Insights

K. Jering

PET Imagining in Cardiac Amyloidosis

NYU Langone

S. Dorbala

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Overview of Genetic Dilated Cardiomyopathy (DCM)

Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes

Q. Bui

How to Make the Diagnosis of ATTR Amyloidosis

Scripps Health

B. Sperry

Transplant in Amyloidosis

Scripps Health

M. Urey

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Hypertrophic Cardiomyopathy: the Past, the Present, and the Future

Collaborative CME and Research Network

E. Braunwald

Using Cardiac MRI to Assess Progression and Treatment Response

The France Foundation

D. Kwon

Advanced Imaging for the Diagnosis of Cardiomyopathy

Scripps Health

P. Parwani

Hypertrophic Cardiomyopathy: Diagnosis and Treatment

Scripps Health

R. C. Mohan

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

Obstructive Hypertrophic Cardiomyopathy vs. Primary Mitral Valve Pro…

Piedmont's Marcus Heart Valve Center

R. Martin, F. Milla

Cardiac Myosin Inhibitors and Other New Treatment Options for Patien…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

J. Silva Enciso

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

Pathophysiologic Relationships between Arrhythmia and Cardiomyopathy…

Brian Olshansky

Hypertrophic Cardiomyopathy: MRI to Mavacamten

Scripps Health

J. Gonzalez